Could a simple liver scan replace risky heart catheters?
NCT ID NCT07222813
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a quick, painless liver scan (FibroScan) can accurately detect high central venous pressure in people with heart failure. Currently, doctors use a catheter inserted into the heart to measure this pressure, which carries risks. The study will enroll 149 adults with suspected or diagnosed heart failure who are already scheduled for catheterization. Researchers will compare the liver scan results to the catheter measurements to see if the scan can reliably identify elevated pressure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FibroScan (non-invasive liver stiffness measurement device)
What this could lead to
If successful, this could provide a safe, quick, and needle-free way to check for fluid buildup in heart failure patients, avoiding the risks of invasive catheterization.
What could go wrong
This is an early-stage diagnostic study, not a treatment trial. The liver stiffness cutoff may not be accurate enough in all patients, and results may not apply to those with liver disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire (CHU) de Rennes - Hopital de Pontchaillou
Rennes, Ile Et Vilaine, 35000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Deutsches Herzzentrum der Charité (DHZC) - Klinik fuer Herz-, Thorax- und Gefaesschirurgie
Berlin, 13353, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Keck Medicine of USC-Norris Healthcare Center - Transplant Clinic
Los Angeles, California, 90033, United States
Contact Email: •••••@•••••
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Minnesota
Minneota, Minnesota, 55455, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location
Dallas, Texas, 75390, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Uniwersytet Medyczny im. Piastow Slaskich we Wroclawiu, Instytut Chorob Serca
Wroclaw, Basse-Silésie, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••